A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

30 Aug 2019

Vaccine alliance in USD 7.4bn funding push

Gavi the Vaccine Alliance is seeking the funds to cover more vaccines, including plans to stockpile the forthcoming Ebola vaccine. Inga Vesp...

27 Aug 2019

Japan’s GHIT ramps up fight against neglected tropical diseases

Writing for the Financial Times Health Report, Andrew Jack explores the recent activity of Japan's Global Health Innovative Technology Fund (GHIT...

05 Aug 2019

How voluntary licensing agreements are transforming HIV care

Rebecca Root writes for Devex about the impact of voluntary licensing for the HIV medicine dolutegravir (DTG) in low-income countries. 

24 Jun 2019

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Writing in The New York Times, Donald G. McNeil Jr. charts the progress made by pharmaceutical companies on access to medicine since the HIV/AIDS cris...

20 May 2019

Industry steps up interest in developing world, fueling doubling of R&D pipeline

The Foundation's 10-year analysis on the pharmaceutical industry and global health is covered by Nick Paul Taylor in this piece for FierceBiotech. Nic...

16 May 2019

Pharma industry improves access to medicines in developing world

Writing for the Financial Times, Clive Cookson covers the Foundation’s latest research report — the first 10-year analysis on how the pharmaceut...

16 May 2019

Pharma is making progress addressing global health, but it’s still a mixed bag

Ed Silverman of STAT news reports on the Foundation's first 10-year progress report on how pharmaceutical companies are responding to calls to improve...

01 Apr 2019

Access to medicines - business as usual?

The Lancet highlights key findings from the 2018 Access to Medicine Index, for example, that while all 20 pharmaceutical companies assessed...

18 Mar 2019

Pharma's Damaged Reputation

Meagan Parrish writes for Pharma Manufacturing, exploring pharma’s current reputation among the general public. Highlighting some of the recent critic...

06 Feb 2019

Insights and expectations on Japanese investors and pharmaceutical companies

Bowen Gu, Investor Engagement Manager at the Access to Medicine Foundation talks to Etsuya Hirose, Nakatsuka Kazunori and Ayaka Hirai in this QUICK ES...

20 Nov 2018

Big pharma leaves big gaps: drugmakers urged to do more for poor

Writing for Reuters, Ben Hirschler covers the 2018 Access to Medicine Index: "Many of the world’s top drugmakers are not doing enough to provide medic...

20 Nov 2018

GSK retains leading position on access to medicines list

Selina McKee of PharmaTimes reports on the results of the 2018 Access to Medicine Index, with highlights from the leaders and details on what makes th...

20 Nov 2018

Coalities nodig voor betere toegang tot medicijnen

Writing for the NRC, Daan van Lent covers the publication of the 2018 Access to Medicine. The article highlights the industry's engagement in priority...

20 Nov 2018

Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018

The Economic Times of India covers the Foundation's latest Access to Medicine Index. The article focuses on the the five companies that are carrying o...

20 Nov 2018

Industry invests in supply chain strategies for low-income countries

Ben Hargreaves of in-Pharma Technologist reports on the 2018 Access to Medicine Index. The article focuses on three areas for ensuring the continuous...

20 Nov 2018

Pharmakonzerne vernachlässigen Medizin für die Ärmsten

Anja Ettel of Die Welt covers the latest results of the Access to Medicine Index. The article focuses on the handful of companies carrying out the maj...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.